393 related articles for article (PubMed ID: 24872138)
1. Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study.
OʼDonnell MR; Wolf A; Werner L; Horsburgh CR; Padayatchi N
J Acquir Immune Defic Syndr; 2014 Sep; 67(1):22-9. PubMed ID: 24872138
[TBL] [Abstract][Full Text] [Related]
2. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.
Yuengling KA; Padayatchi N; Wolf A; Mathema B; Brown T; Horsburgh CR; OʼDonnell MR
J Acquir Immune Defic Syndr; 2018 Dec; 79(4):474-480. PubMed ID: 30212394
[TBL] [Abstract][Full Text] [Related]
3. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.
Daftary A; Padayatchi N; O'Donnell M
Glob Public Health; 2014; 9(9):1107-16. PubMed ID: 25035943
[TBL] [Abstract][Full Text] [Related]
4. Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.
Padayatchi N; Gopal M; Naidoo R; Werner L; Naidoo K; Master I; O'Donnell MR
J Antimicrob Chemother; 2014 Nov; 69(11):3103-7. PubMed ID: 24986495
[TBL] [Abstract][Full Text] [Related]
5. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
OʼDonnell MR; Pillay M; Pillay M; Werner L; Master I; Wolf A; Mathema B; Coovadia YM; Mlisana K; Horsburgh CR; Padayatchi N
J Acquir Immune Defic Syndr; 2015 Aug; 69(5):536-43. PubMed ID: 25886924
[TBL] [Abstract][Full Text] [Related]
6. Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients.
Kvasnovsky CL; Cegielski JP; Erasmus R; Siwisa NO; Thomas K; der Walt ML
J Acquir Immune Defic Syndr; 2011 Jun; 57(2):146-52. PubMed ID: 21297482
[TBL] [Abstract][Full Text] [Related]
7. Successful integration of tuberculosis and HIV treatment in rural South Africa: the Sizonq'oba study.
Gandhi NR; Moll AP; Lalloo U; Pawinski R; Zeller K; Moodley P; Meyer E; Friedland G;
J Acquir Immune Defic Syndr; 2009 Jan; 50(1):37-43. PubMed ID: 19295333
[TBL] [Abstract][Full Text] [Related]
8. Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.
Thomas TA; Shenoi SV; Heysell SK; Eksteen FJ; Sunkari VB; Gandhi NR; Friedland G; Shah NS
Int J Tuberc Lung Dis; 2010 Oct; 14(10):1244-51. PubMed ID: 20843414
[TBL] [Abstract][Full Text] [Related]
9. Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.
Ndjeka N; Conradie F; Schnippel K; Hughes J; Bantubani N; Ferreira H; Maartens G; Mametja D; Meintjes G; Padanilam X; Variava E; Pym A; Pillay Y
Int J Tuberc Lung Dis; 2015 Aug; 19(8):979-85. PubMed ID: 26162365
[TBL] [Abstract][Full Text] [Related]
10. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
[TBL] [Abstract][Full Text] [Related]
11. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
Bionghi N; Daftary A; Maharaj B; Msibi Z; Amico KR; Friedland G; Orrell C; Padayatchi N; O'Donnell MR
BMC Infect Dis; 2018 Apr; 18(1):171. PubMed ID: 29642874
[TBL] [Abstract][Full Text] [Related]
12. Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
Müller B; Chihota VN; Pillay M; Klopper M; Streicher EM; Coetzee G; Trollip A; Hayes C; Bosman ME; Gey van Pittius NC; Victor TC; Gagneux S; van Helden PD; Warren RM
PLoS One; 2013; 8(8):e70919. PubMed ID: 24058399
[TBL] [Abstract][Full Text] [Related]
13. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study.
Naidoo P; Peltzer K; Louw J; Matseke G; McHunu G; Tutshana B
BMC Public Health; 2013 Apr; 13():396. PubMed ID: 23622516
[TBL] [Abstract][Full Text] [Related]
14. High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen.
Ndjeka N; Schnippel K; Master I; Meintjes G; Maartens G; Romero R; Padanilam X; Enwerem M; Chotoo S; Singh N; Hughes J; Variava E; Ferreira H; Te Riele J; Ismail N; Mohr E; Bantubani N; Conradie F
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30361246
[TBL] [Abstract][Full Text] [Related]
15. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.
Dheda K; Shean K; Zumla A; Badri M; Streicher EM; Page-Shipp L; Willcox P; John MA; Reubenson G; Govindasamy D; Wong M; Padanilam X; Dziwiecki A; van Helden PD; Siwendu S; Jarand J; Menezes CN; Burns A; Victor T; Warren R; Grobusch MP; van der Walt M; Kvasnovsky C
Lancet; 2010 May; 375(9728):1798-807. PubMed ID: 20488525
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
Nkurunziza J; Karstaedt AS; Louw R; Padanilam X
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1469-1474. PubMed ID: 30606319
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
[TBL] [Abstract][Full Text] [Related]
19. Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in Kwazulu-Natal, South Africa.
Peltzer K; Friend-du Preez N; Ramlagan S; Fomundam H; Anderson J
Afr J Tradit Complement Altern Med; 2009 Dec; 7(2):125-37. PubMed ID: 21304624
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection.
O'Donnell MR; Padayatchi N; Kvasnovsky C; Werner L; Master I; Horsburgh CR
Emerg Infect Dis; 2013 Mar; 19(3):416-24. PubMed ID: 23622055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
